GOLDMAN SACHS GROUP INC - PROTARA THERAPEUTICS INC ownership

PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 42 filers reported holding PROTARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$781,000
-41.4%
152,847
-22.5%
0.00%
Q4 2021$1,332,000
+23.4%
197,302
+26.5%
0.00%
Q3 2021$1,079,000
-16.2%
155,973
+17.9%
0.00%
Q2 2021$1,288,000132,2570.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,674,031$13,664,0004.24%
Ikarian Capital, LLC 296,426$1,515,0000.20%
DLD Asset Management, LP 229,531$1,173,0000.07%
Orbimed Advisors 830,641$4,245,0000.07%
Boxer Capital, LLC 209,227$1,069,0000.06%
Perceptive Advisors 383,526$1,960,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,000$327,0000.01%
Baker Brothers Advisors 199,671$1,020,0000.01%
Trexquant Investment LP 16,313$83,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 27,591$141,0000.00%
View complete list of PROTARA THERAPEUTICS INC shareholders